Skip to content

Neurophysiologic Maturation Index for Late Preterm Infants

Neurophysiologic Maturation Index: NEMO Project for Late Preterm Infants

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT02156817
Acronym
NEMO Project
Enrollment
26
Registered
2014-06-05
Start date
2014-03-31
Completion date
2017-06-02
Last updated
2025-10-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Neurophysiologic Maturation

Keywords

Amplitude integrated electroencephalogram, Heart rate variability, Respiratory rate variability, Preterm Infants, Length of Hospital Stay

Brief summary

Late preterm infants contribute to significant neonatal intensive care unit health care resource utilization because of their sheer numbers. Determinants of the length of hospitalization (LOH) in this population are understudied. Gestational age (GA) is used most commonly as a predictor for LOH but there are many limitations including inaccurate dating and morbidities of prematurity which at least partly related to neurophysiological immaturity. The latter can be assessed by amplitude integrated electroencephalogram (aEEG, a simplified 5 lead EEG), and possibly by heart rate variability (HRV) and respiratory variability (RV). All 3 are non-invasive tests that can be done at the bedside. Our study hypothesis is to determine if neurophysiologic maturation as assessed by aEEG, HRV and RV within 24-96 hours following birth improves the correlation between gestational age and length of hospitalization compared to gestational age alone.

Interventions

OTHERAmplitude integrated electroencephalogram, Cardiorespiratory signal acquisition

Sponsors

McGill University Health Centre/Research Institute of the McGill University Health Centre
CollaboratorOTHER
Wayne State University
CollaboratorOTHER
Brown University
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
1 Days to 4 Days
Healthy volunteers
No

Inclusion criteria

* Gestational age of 340-346 weeks by Obstetric criteria (presence of a sure LMP or sonogram performed in the first trimester, or agreement between LMP and a sonogram performed between the first trimester and 20 weeks) * Admitted to a NICU of a participating institution * Post-natal age less than 96 hours

Exclusion criteria

* Major congenital anomaly/genetic anomaly * Growth restriction (birth weight \< 10%, Fenton growth curves) * Unsure obstetric dating (e.g., absence of a sure LMP without a sonogram, earliest sonogram performed after 20 weeks without a sure LMP, or discrepancy between LMP and sonogram) * Exposure to medications within the preceding 12 hrs which may affect CNS function (e.g., fentanyl, morphine, midazolam) * Neonatal seizures * Neonatal abstinence syndrome secondary to in-utero exposure to narcotics, methadone etc, or at high risk for development of abstinence * Hypoxia-ischemia defined as the combination of fetal acidemia (cord gas or blood gas within 1 hour of birth: pH ≤ 7.15 or BE ≥ -10mEq/L), need for resuscitation at birth (PPV ± chest compressions or medications), and evidence of encephalopathy (Stage 1, 2 or 3 Sarnat). Stage 1 encephalopathy will be defined based on the level of consciousness which is characterized by a hyper-alert state, apparent alertness, and irritability. In the absence of a cord or early post-natal blood gas, there must be a history of a perinatal event which may have compromised oxygenation or blood flow to the fetus. * Infants who are expected to be on mechanical (via an endotracheal tube) or high frequency ventilation for the first 96 hours after birth. * Inability to obtain the informed consent

Design outcomes

Primary

MeasureTime frameDescription
Magnitude of variance, R square2 yearslinear regression model: LOH = intercept + b1GA + b2aEEG + b3HRV + b4RV + error term; b1 - b4 represents the weight of each variable to explain the variance of the equation (R2), GA is gestational age, aEEG is amplitude integrated EEG, HRV is heart rate variability, RV is respiratory variability, LOH is length of hospital stay

Secondary

MeasureTime frameDescription
Amplitude integrated electroencephalogram (aEEG)participants will be followed for the duration of hospital stay, an expected average of 5 weeksnumber of cycles/hour, the lower border voltage, the span voltage or the percent of the tracing which is discontinuous
Heart rate variability (HRV)participants will be followed for the duration of hospital stay, an expected average of 5 weeksstandard deviation of the R-R interval, sample asymmetry and sample entropy
Respiratory variability (RV)participants will be followed for the duration of hospital stay, an expected average of 5 weeksinstantaneous respiratory effort, phase between ribcage and abdomen, amplitude of the signal, pause metrics and movement artifact metrics

Countries

Canada, United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026